NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.

Dawn M. Torres; Stephen A. Harrison

doi:10.1038/nrgastro.2013.138

NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.

Dawn M. Torres^*, Stephen A. Harrison

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

33 Scopus citations

Abstract

With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.

Original language	English
Pages (from-to)	510-511
Number of pages	2
Journal	Nature Reviews Gastroenterology and Hepatology
Volume	10
Issue number	9
DOIs	https://doi.org/10.1038/nrgastro.2013.138
State	Published - 2013
Externally published	Yes

Access to Document

10.1038/nrgastro.2013.138

Cite this

@article{372a137e769f430b95938f7fb2aa3e9a,

title = "NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.",

abstract = "With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.",

author = "Torres, {Dawn M.} and Harrison, {Stephen A.}",

year = "2013",

doi = "10.1038/nrgastro.2013.138",

language = "English",

volume = "10",

pages = "510--511",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

number = "9",

}

TY - JOUR

T1 - NAFLD

T2 - Predictive value of ALT levels for NASH and advanced fibrosis.

AU - Torres, Dawn M.

AU - Harrison, Stephen A.

PY - 2013

Y1 - 2013

N2 - With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.

AB - With expanding waistlines, the prevalence of NAFLD has burgeoned to become the leading cause of chronic liver disease in the USA. A subset of patients with NAFLD meet criteria for NASH with its inherent risk of progression to cirrhosis. Verma et al. addressed the utility of alanine aminotransferase levels for predicting NASH or advanced fibrosis to decide who would benefit from the definitive test of liver biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84899035652&partnerID=8YFLogxK

U2 - 10.1038/nrgastro.2013.138

DO - 10.1038/nrgastro.2013.138

M3 - Comment/debate

C2 - 23897284

AN - SCOPUS:84899035652

SN - 1759-5045

VL - 10

SP - 510

EP - 511

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

IS - 9

ER -

NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis.

Abstract

Access to Document

Fingerprint

Cite this